FDA NDC Directory · JSON-LD · Markdown

Adenosine

NDC 68083-157 · HUMAN PRESCRIPTION DRUG · SOLUTION

Labeler / ManufacturerGland Pharma Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA206778
Dosage form / routeSOLUTION · INTRAVENOUS
Active ingredientsADENOSINE (3 mg/mL)
Marketing started20170113
Package count1

External sources

Source: openFDA. Public-domain (CC0).